Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite update adds Revision: v3.4.2 and removes the government funding status notice (Revision: v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice about potential delays and updated operations status information with a link to opm.gov. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle added; QC-related metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the prior QC label and version, and a 'No FEAR Act Data' item is now shown instead of the former 'No FEAR Act data' entry.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter changes include removal of the HHS Vulnerability Disclosure link and addition of a site revision label 'Revision: v3.3.3' (replacing 'Revision: v3.3.2'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThese changes are minor textual updates to the PubMed publications notes and revision labels, with no impact on study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.